Accéder au contenu
Merck

Effect of sodium molybdate on the status of lipids, lipid peroxidation and antioxidant systems in alloxan-induced diabetic rats.

Clinica chimica acta; international journal of clinical chemistry (2004-06-15)
Saraswathi R Panneerselvam, Swaminathan Govindasamy
RÉSUMÉ

Diabetes mellitus manifests itself in a wide variety of complications and the symptoms of the disease are multi-factorial. The lipid peroxidation (LPO) and antioxidant status were investigated in hemolysate, liver and kidney in alloxan-induced diabetic rats and the effect of molybdate supplementation on antioxidant defense systems. Diabetic rats exhibited an increase in the levels of lipids, lipid peroxidation and decrease in antioxidant status when compared to control rats. Oral administration of molybdate to diabetic rats for 30 days significantly reduced the levels of lipids like cholesterol, triglycerides, phospholipids and lipid peroxidation whereas increased the activities of antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and reduced glutathione (GSH). Molybdate prevents oxidation of lipids and protects antioxidant systems in experimental diabetic rats, and thus, may be useful for the prevention or early treatment of diabetic mellitus.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Sodium molybdate dihydrate, ≥99.5%
Sigma-Aldrich
Sodium molybdate dihydrate, ACS reagent, ≥99%
Sigma-Aldrich
Sodium molybdate, ≥98%
Sigma-Aldrich
Sodium molybdate dihydrate, ≥99.5%, suitable for plant cell culture
Sigma-Aldrich
Sodium molybdate, anhydrous, powder, −100 mesh particle size, 99.9% trace metals basis
Sigma-Aldrich
Sodium molybdate dihydrate, 99.99% trace metals basis